Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026)

Verastem (VSTM) posted quarterly Total Non-Current Liabilities of $146.0 million for Q1 2026, up 33.5% year-over-year from $109.4 million in Q1 2025, and down 4.93% quarter-over-quarter from $153.6 million in Q4 2025.

Analysis

Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Verastem's Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $146.0 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 33.5% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $146.0 million (up 33.5% YoY), while the FY2025 annual figure was $153.6 million, up 112.65% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $146.0 million, down from $153.6 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $153.6 million in Q4 2025, with the low at $68.0 million in Q3 2024.
  • The 4-year median for Total Non-Current Liabilities is $126.7 million (2025), against an average of $114.7 million.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities declined 5.21% in 2024, then surged 112.65% in 2025.
  • Verastem's Total Non-Current Liabilities stood at $71.8 million in 2023, then gained by 0.65% to $72.2 million in 2024, then soared by 112.65% to $153.6 million in 2025, then fell by 4.93% to $146.0 million in 2026.
  • Business Quant data shows VSTM's Total Non-Current Liabilities at $146.0 million in Q1 2026, $153.6 million in Q4 2025, and $144.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 40.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 3.92 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.53 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.88 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.32 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.17 Bn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 156.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.53 Mn
Mar 31, 2026 146.03 Mn
Dec 31, 2025 153.60 Mn
Sep 30, 2025 144.09 Mn
Jun 30, 2025 138.45 Mn
Mar 31, 2025 109.39 Mn
Dec 31, 2024 72.23 Mn
Sep 30, 2024 68.02 Mn
Sep 30, 2023 71.76 Mn
Jun 30, 2020 83.29 Mn
Mar 31, 2020 84.30 Mn
Dec 31, 2019 137.00 Mn
Sep 30, 2019 170.21 Mn
Jun 30, 2019 168.73 Mn
Mar 31, 2019 154.41 Mn
Dec 31, 2018 151.81 Mn
Sep 30, 2018 74.98 Mn
Jun 30, 2018 45.65 Mn
Mar 31, 2018 29.76 Mn
Dec 31, 2017 31.96 Mn